Anudishi Tyagi, PhD^1*, Stanley Ly^2*, Bin Yuan, PhD^3*, Fouad El-Dana, M.D.^1*, Vivek Anand, PhD^1*, Appalaraju Jaggupilli, PhD^1*, Gautam Borthakur, MD⁴, Jason M Foulks, PhD^5*, Steven L. Warner, PhD⁵ and Venkata Lokesh Battula, PhD⁶

¹Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Section of Molecular Hematology and Therapy, Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
³Leukemia, University of Texas MD Anderson Cancer Center, Houston
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Sumitomo Pharma Oncology, Lehi, UT
⁶Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Qingyu Xu^1*, Alexander Streuer, MD^1*, Johann-Christoph Jann, MD^1*, Eva Altrock, PhD^1*, Nanni Schmitt, MSc^1*, Johanna Flach, PhD^1*, Carla Sens-Albert, PhD^1*, Felicitas Rapp, PhD^1*, Julia Wolf^1*, Verena Nowak^1*, Nadine Weimer^1*, Julia Obländer^1*, Iris Palme^1*, Ahmed Jawhar, MD^2*, Ali Darwich, MD^2*, Cleo-Aron Weis, MD^3*, Alexander Marx, MD^3*, Patrick Wuchter, MD⁴, Victor Costina^5*, Evelyn Jäger^5*, Elena Sperk, MD^1*, Michael Neumaier, MD^5*, Alice Fabarius, PhD^1*, Georgia Metzgeroth, MD^1*, Florian Nolte, MD^1*, Laurenz Steiner, MD^1*, Mohamad Jawhar, MD^1*, Wolf-Karsten Hofmann, MD¹, Vladimir Riabov, PhD^1* and Daniel Nowak, MD^1*

¹Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
²Department of Orthopedic Surgery, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
³Institute of Pathology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
⁴Institute of Transfusion Medicine and Immunology, German Red Cross Blood Service Baden-Württemberg-Hessen, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
⁵Institute of Clinical Chemistry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

Jiamin Guo, MSc^1,2*, Ralf Buettner, PhD³, Li Du, PhD^3,4*, Yanzhong Yang, PhD^5*, Zhenlong Li, PhD^2* and Steve T Rosen, MD^6,7,8

¹Irell & Manella Graduate School of Biological Sciences, Beckman Research Institute City of Hope, Duarte, CA
²Department of Hematology & Hematopoietic Cell Transplantation, Beckman Research Institute City of Hope, Duarte, CA
³Judy and Bernard Briskin Center for Multiple Myeloma Research, Beckman Research Institute City of Hope, Duarte, CA
⁴Toni Stephenson Lymphoma Center, Beckman Research Institute City of Hope, Duarte, CA
⁵Department of Cancer Genetics and Epigenetics, Beckman Research Institute City of Hope, Duarte, CA
⁶Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁷City of Hope National Medical Center, Duarte, CA
⁸City of Hope Comprehensive Cancer Center, Duarte, CA

Vilma Dembitz^1*, Hannah Lawson^1*, Celine Philippe^2*, Richard J. Burt, MBBS PhD^3,4*, Sophie James^5*, Aoife S.M. Magee^1*, Keith Woodley, PhD^6*, Jozef Durko^7*, Joana Campos^8*, Michael James Austin^9*, Ana Rio-Machin, PhD^9*, Pedro Casado Izquierdo, PhD^9*, Findlay Bewicke-Copley, PhD^5,9, Giovanny Rodriguez Blanco^10*, Bela Patel^5*, Lori Hazlehurst^11*, Barrie Peck^12*, Andrew Finch^9*, Pedro Cutillas, PhD^13*, Jude Fitzgibbon, PhD⁸, Mariia Yuneva, Phd^14*, Kevin Rouault-Pierre, PhD^1*, John Copland III^15*, Kamil Kranc^8* and Paolo Gallipoli, MD⁹

¹Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
²Barts Cancer Institute, Queen Mary University of London, London, ENG, United Kingdom
³The Francis Crick Institute, London, United Kingdom
⁴Cancer Institute, University College London, London, United Kingdom
⁵Barts Cancer Institute, London, United Kingdom
⁶Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, ENG, United Kingdom
⁷Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, GBR
⁸Queen Mary University of London, London, GBR
⁹Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
¹⁰University of Edinburgh, Edinbugh, United Kingdom
¹¹Modulation Therapeutics, Morgantown, WV
¹²Barts Cancer Institute, London, GBR
¹³Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
¹⁴Francis Crick Institute, London, United Kingdom
¹⁵Mayo Clinic, Jacksonville, FL

James Palacino, PhD^1*, Pedro Lee, PhD^2*, Hangyeol Jeong^2*, Yeonjoon Kim^2*, Yoojin Song^2*, Uttapol Permpoon, PhD^2*, Wesley Wong, PhD^1*, Chen Bai^1*, Nathan Fishkin, PhD^1*, Khuloud Takrouri, PhD^1*, Eunjin Yu, PhD^2*, Yong Yi^1*, Anna Skaletskaya^1*, Ki-Hwan Chang^2*, Min-Soo Kim^2*, Da-Yeong Kim^2*, Dong-Ki Choi^2* and Peter U Park, PhD^1*

¹Orum Therapeutics, Cambridge, MA
²Orum Therapeutics, Daejeon, Korea, Republic of (South)

Bing Z Carter, PhD¹, Po Yee Mak^1*, Wenjing Tao^1*, Lauren B Ostermann^1*, Duncan Mak, BSc, MPhil^1*, Boazhen Ke^2*, Peter Ordentlich, PhD^3*, Gerard M. McGeehan, PhD^3* and Michael Andreeff, MD, PhD¹

¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
³Syndax Pharmaceuticals, Inc., Waltham, MA

Huijun Huang, MD^1*, Jinqin Liu^2*, Lin Yang^3*, Yue Chen^4*, Robert Peter Gale⁵ and Zhijian Xiao, MD&PhD^6*

¹Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, AL, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Tianjin, CHN
⁴State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China
⁵Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
⁶State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Jifeng Yu, MD^1*, Song Li^2*, Dianze Chen^2*, Dandan Liu^2*, Huiqin Guo^2*, Chunmei Yang^2*, Wei Zhang^2*, Li Zhang^2*, Gui Zhao^2*, Xiaoping Tu^2*, Liang Peng^2*, Sijin Liu^2*, Xing Bai^2*, Yongping Song^3*, Zhongxing Jiang, MD^4*, Ruliang Zhang^2* and Wenzhi Tian^5*

¹The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
²ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd, Shanghai, China
³Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China
⁴Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
⁵ImmuneOnco Biopharmaceuticals(Shanghai) Inc., Shanghai, China

Min Lu, PhD, MD^1,2,3, Lijuan Xia^1* and Ronald Hoffman, MD^1,3,4

¹Tisch Cancer Institute, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
²Tisch Cancer Institute, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Elmhurst, NY
³MPN Research Consortium, New York, NY
⁴Division of Hematology/Medical Oncology, Tisch Cancer Institute, Ichan School of Medicine at Mount Sinai, New York, NY

Jennifer N. Saultz, DO¹, Daniel Bottomly^2*, Faith Burns^3*, Kaelan Byrd^3*, Yoko Kosaka, PhD^4*, Shannon K. McWeeney, PhD^2*, Stephen E. Kurtz, PhD^5*, Guang Fan, MD, PhD⁶, Andy Kaempf^7*, Karen McGovern, PhD^8*, Lei Wang^8*, Marta Sanchez-Martin^8*, Dan S Kaufman, MD, PhD⁹, Evan F. Lind, PhD¹⁰ and Jeffrey W. Tyner³

¹Oregon Health and Science University, Portland, OR
²Knight Cancer Institute, Division of Bioinformatics and Computational Biomedicine, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR
³Oregon Health & Science University, Portland, OR
⁴Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁵Knight Cancer Institute, Mail code: KR-HEM, Oregon Health & Science University, Portland, OR
⁶Department of Pathology, Oregon Health and Science University, Portland, OR
⁷Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁸IKENA, Boston, MA
⁹Department of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA
¹⁰Microbiology and Immunology, OHSU, Portland, OR

Harish Kumar, PhD^1*, Aditi Dhir, MD^2*, Andrew J. Paterson, PhD^3*, Nick R Anderson, BS⁴, Shaowei Qiu^5*, Xinyang Zhao, PhD⁶, Rui Lu, PhD⁷ and Ravi Bhatia, MD⁴

¹Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, UAB, Birmingham, AL
²University of Alabama at Birmingham, Birmingham, AL
³Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL
⁴Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
⁵Division of Hematology and Oncology, Department of Medicine, University of Alabama at birmingham, Birmingham, AL
⁶Department of Biochemistry and Molecular Genetics, University of Alabama At Birmingham, Birmingham, AL
⁷Division of Hematology and Oncology, Department of Medicine, University of Alabama At Birmingham, Birmingham, AL

Alexander Marr^1*, Soumendrakrishna Karmahapatra, PhD^1*, Dominique Corbin, BS^1*, Yerdanos Asemelash, BA^1*, Steven Sher^2*, Shaneice Renee Mitchell, PhD^3*, Bonnie K Harrington, DVM, PhD⁴, Shelley Orwick, BS^1*, Larry Beaver, BS^1*, Ronni Wasmuth, BS^1*, Virginia Goettl, DVM, PhD^1*, Alice S. Mims, MD¹, Karilyn T. Larkin, MD⁵, Sumithira Vasu, MBBS¹, Meixiao Long, MD¹, James S. Blachly, MD¹, Ramiro Garzon, MD¹, John C. Byrd, MD⁶, Rosa Lapalombella, PhD⁷ and Nicole Grieselhuber, MD, PhD¹

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²Division of Hematology, Department of Internal Medicine, THE OHIO STATE UNIVERSITY, COLUMBUS, OH
³Department of Pathology, Stanford University, Stanford, CA
⁴College of Veterinary Medicine, The Ohio State University, Columbus, OH
⁵Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
⁶University of Cincinnati College of Medicine, Cincinnati, OH
⁷Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH

Mengbao Du^1*, Mowang Wang^1*, Meng Liu^1*, Shan Fu^1*, Yu Lin^1*, Jian Yu, Ph.D.^1*, Xiaohong Yu^1*, He Huang, Ph.D., M.D.², Haowen Xiao^3* and Limengmeng Wang, PhD^1*

¹Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
³Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China, Hangzhou, China

Todd Shearer, PhD, MS^1*, Rex L. Williams Jr.^1*, Mark Johnson^1*, Ewa Cendrowicz^2*, Cathrine Leonowens^3*, Margaret Smith^1*, Todd Baughman^1*, Caroline J. Breitbach^1*, L. Mary Smith, PhD^1*, Michael Burgess^1* and Shinta Cheng^1*

¹SpringWorks Therapeutics, Stamford, CT
²ICON, Assen, Netherlands
³Nuventra Pharma Sciences, Durham, NC

Valerio Ciaurro^*, Anna Skwarska, PhD^*, Naval Daver, MD and Marina Konopleva, MD, PhD

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Marie Sabatier, PhD^1*, Rudy Birsen, MD^2*, Laura Lauture^1*, Léa Goupille^1*, Clement Larrue, PhD^3*, Sarah Mouche^4*, Christian Recher, MD⁵, Jerome Tamburini, MD, PhD^6,7* and Jean-Emmanuel Sarry, PhD^1*

¹Cancer Research Center of Toulouse, Toulouse, France
²Cochin Hospital, Hematology Department, Paris, France
³Translational Research Centre In Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland
⁴Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland
⁵Service d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
⁶Institute Cochin Centre De Recherche, Paris, France
⁷Translational Research Center for Oncohematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Chi-Yang Tseng¹, Fang-Yu Lo^1*, Yu-Hsuan Fu, M.S.^1,2*, Da-Liang Ou, PhD^3*, Hsin-An Hou, MD, PhD⁴ and Liang-In Lin, PhD¹

¹Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan
²Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
³Department of Oncology, National Taiwan University, Taipei, Taiwan
⁴Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Jay Gamma^1*, Erwan Beauchamp^1*, Qiang Liu, PhD, BSc², Aishwarya Iyer^1*, Megan Yap^1*, Zoulika Zak^1*, Cassidy Ekstrom^1*, Krista Vincent^1*, Joseph Brandwein, MD³, Jean C.Y. Wang, MD⁴, Naveen Pemmaraju, MD⁵, Gautam Borthakur, MD⁵, John R. Mackey, MD^6,7,8* and Luc G. Berthiaume, PhD^7,9*

¹University of Alberta, Edmonton, AB, Canada
²Princess Margaret, University Health Network, Toronto, ON, Canada
³Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
⁴Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Oncology, University of Alberta, Edmonton, AB, Canada
⁷Pacylex Pharmaceuticals, Inc., Edmonton, AB, Canada
⁸Cross Cancer Institute, Edmonton, Canada
⁹Department of Cell Biology, University of Alberta, Edmonton, AB, Canada

Daniela Bellarosa, PhD^1*, Sonia Zicari, PhD^1*, Giuseppe Merlino, PhD^1*, Alessio Fiascarelli, PhD^1*, Diego Bisignano^1*, Francesco Belli^1*, Clelia Irrissuto^1*, Simone Talucci^1*, Maria Luisa Iannitto, PhD^1*, Mario Bigioni, PhD^1*, Alessandro Bressan, PhD^1*, Krzysztof Brzózka, PhD^2*, Gabriel Ghiaur, MD, PhD³ and Monica Binaschi, PhD^1*

¹Experimental and Translational Oncology Department, Menarini Ricerche S.p.A., Pomezia (Rome), Italy
²Ryvu Therapeutics, Cracow, Poland
³Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD

Chunxiao He^1*, Dengyang Zhang, PhD^1*, Yao Guo, PhD^1*, Yuming Zhao^1*, Junbin Huang^2*, Hongman Xue, MD, PhD^1*, Chun Chen, MD, PhD^1*, Yun Chen, PhD^1* and Zhizhuang Joe Zhao, PhD³

¹The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
²Sun Yat-Sen University, Shenzhen, China
³Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Priyanka Sharma, PhD¹, Sujan Piya, PhD^2,3, Natalia Baran, MD, PhD⁴, Muharrem Muftuoglu, MD⁴, Mahesh Basyal, BSc^1*, Vivian Ruvolo, MS^4*, Christopher J. Hindley, PhD^5*, Kim-Hien Dao, DO⁶, Martin Sims, PhD^5*, Michael Andreeff, MD, PhD⁴ and Gautam Borthakur, MD⁴

¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Pearland, TX
³Division of Pathology and Laboratory Medicine Clinical Trial Operation, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Astex Pharmaceuticals, Cambridge, United Kingdom
⁶Astex Pharmaceuticals, Inc., Pleasanton, CA

Stefan D Gross, PhD^1*, Christopher A. Eide^2*, Michael R Burkard^1*, Anna Reister Schultz^2*, Monette A Aujay^1*, Samuel Kintz^1*, Brian J. Druker² and Joseph P Lyssikatos, PhD^1*

¹Enliven Therapeutics, Boulder, CO
²Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR

Kotoko Yamatani, MD^1*, Abhishek Maiti, MBBS², Tatsuro Watanabe, PhD^3*, Kaori Saito^1*, Kala Hayes^4*, Sonoko Kinjo, PhD^5*, Kazuho Ikeo, PhD^6*, Takashi Miida, MD, PhD^1*, Shinya Kimura, MD, PhD^3,7*, Courtney D. DiNardo, MD, MSCE⁴, Xiaoping Su, PhD^8*, Yoko Tabe, MD, PhD^1,4,9 and Marina Konopleva, MD, PhD¹⁰

¹Department of Clinical Laboratory Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan
²Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
³Department of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga-city, Japan
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Center for Information Biology, National Institute of Genetics, Shizuoka, Japan
⁶Centers for Information Biology, National Institute of Genetics, Shizuoka, Japan
⁷Saga University, Saga, Japan
⁸Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Next Generation Hematology Laboratory Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan
¹⁰Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Chee Chean Dang, PhD^1*, Ka Lam Nelson Ng^2*, Wing Lam^1*, Xiao Yuan Zeng^2*, Li Chuan Zheng^2*, Koon Chuen Chan^2*, Timothy Chi Chun Ng^2*, Tsz Ho Kwok, MPhil^1*, Wing Yan Leung^1*, Michael Shing Yan Huen^3*, Carmen Chak Lui Wong^4,5*, Zhi Xun Dou^6,7*, Tak Wah Mak, PhD, DSc^4,8*, Cheuk Him Man^1* and Anskar Yu Hung Leung, MD, PhD²

¹Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
²Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
³School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
⁴Department of Pathology, The University of Hong Kong, Hong Kong, China
⁵State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China
⁶Harvard Stem Cell Institute, Harvard University, Cambridge, MA
⁷Center for Regenerative Medicine, Massachusetts General Hospital, Boston
⁸The Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Center, Toronto, Canada

Sebastian E. Koschade, MD^1*, Kevin Klann, PhD^1*, Shabnam Shaid, MD^1*, Binje Vick, PhD^2*, Jan A. Stratmann, MD^1*, Marlyn Thölken^1*, Laura M. Meyer^1*, The Duy Nguyen, PhD^1*, Julia Campe^1*, Laura M. Moser, MD^1*, Susanna Hock^1*, Fatima Baker^1*, Christian Meyer, PhD^3*, Frank Wempe, PhD^1*, Hubert Serve, MD¹, Evelyn Ullrich, MD¹, Irmela Jeremias, MD, PhD⁴, Christian Münch, PhD^1* and Christian H. Brandts, MD^1*

¹Goethe University Frankfurt, Frankfurt, Germany
²Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany
³Vanderbilt University, Nashville, TN
⁴Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Munich, Germany

Mohammad Azhar^1*, Zachary Kincaid, BS^2*, Meenu Kesarwani^3*, Tahir Latif, MD⁴, Sekhu Ansari, PhD¹, William Seibel, PhD^5* and Mohammad Azam, PhD⁶

¹Pathology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
²Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
³Cincinnati Childrens Hospital Medical Center, Mason, OH
⁴University of Cincinnati College of Medicine, Cincinnati, OH
⁵Cincinnati Children's Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, OH
⁶CBDI, Cincinnati Children's Hospital, Cincinnati, OH